SUMMARY
The clinical and academic interests of Arthur Beyder, M.D., Ph.D., focus on disorders of gut-brain interaction. This is a group of common conditions affecting up to 4 in 10 American adults and exemplified by irritable bowel syndrome and functional dyspepsia. There is a growing need for diagnostic and treatment options for these conditions.
Digestive disorders involving gut-brain interaction often share a common pathophysiological theme of disrupted mechanobiology. In these disorders, changes in the sensing and processing of physical forces contribute to altered motility and sensation and other symptoms.
The action of mechanosensitive ion channels and disrupted gut mechanobiology represent clinically relevant mechanisms in patients with disorders of gut-brain interaction. In Dr. Beyder's laboratory, researchers focus on mechanosensitive ion channels as central molecular drivers of these disorders, defining how altered force sensing at the cellular level leads to disease.
Dr. Beyder studies mechanosensitive ion channels, which function as molecular switches that convert forces into cellular signals and are common drug targets. He places particular emphasis on ion channels that respond to mechanical forces in a variety of cell types. Dr. Beyder's team uses a wide range of powerful experimental approaches, from recording electrical signals in living cells to visualizing how tissues respond to force in real time.
By combining advanced imaging, genetics and biophysics, Dr. Beyder explores how physical forces shape gut function and how these processes break down in disease. Additionally, his team develops new experimental tools that have led to three U.S. patents. This work has helped define how mechanosensitive signaling supports healthy gastrointestinal function and how it is disrupted in disease.
Dr. Beyder's laboratory is part of the internationally recognized Enteric Neuroscience Program (ENSP) group at Mayo Clinic. Dr. Beyder's lab collaborates widely with members of the ENSP group and with several Mayo labs, including those focused on cardiology, anesthesia and pulmonary medicine. They also collaborate widely with national and international colleagues.
The goal of Dr. Beyder's work is to transform how disorders of gut‑brain interaction are understood, diagnosed and treated. By uncovering the fundamental mechanisms that govern how the gut senses and responds to physical forces, his laboratory aims to enable more-precise mechanism‑based diagnoses and targeted therapies.
Dr. Beyder's work has been recognized with multiple national awards for research excellence and innovation in gastroenterology and mechanobiology.
Focus areas
- Molecular mechanisms of enteroendocrine cell mechanosensing. Enteroendocrine cells act as specialized gut touch sensors that — similar to the skin's sensors — respond to physical forces such as stretch, pressure and movement within the intestinal lining. By translating mechanical cues into biological signals, these cues play a central role in coordinating gut function. These cells release hormones such as serotonin and GLP‑1. Dr. Beyder's team focuses on how their force‑sensing capabilities shape communication between the gut and the nervous system in health and disease.
- Smooth muscle cell mechanosensitivity. Gastrointestinal smooth muscle cells continuously sense mechanical forces to drive coordinated movement of the gut. With aging, and in conditions such as inflammatory bowel disease, the physical properties of the gut wall change, placing new demands on how these cells detect and respond to force. Dr. Beyder focuses on defining the molecular mechanisms of smooth muscle cell mechanosensing and how their disruption leads to dysfunction.
-
Artificial intelligence (AI)-driven analysis of gut-brain disorders. Dr. Beyder's team focuses on translating discoveries in the laboratory to benefit patients. The laboratory is developing AI‑based approaches to decode complex physiological data generated by clinical tests used in disorders of gut-brain interaction. These tests include intestinal manometry, which is an advanced diagnostic technique that directly measures bowel wall contractility.
By applying machine learning and advanced pattern recognition to high‑dimensional motility recordings, the team aims to reveal physiological signatures that are invisible to conventional analysis. This approach enables improved disease phenotyping, linking motility patterns to underlying mechanobiological mechanisms. It also ultimately supports more-precise diagnosis and individualized treatment strategies.
- Training and mentorship. Dr. Beyder is strongly committed to training and mentoring the next generation of physician-scientists and researchers. His laboratory has trained Medical Scientist Training Program (M.D. and Ph.D.) students, clinical T32 fellows and postdoctoral fellows who have advanced to independent faculty positions. This training environment integrates rigorous mechanistic science with translational and clinical relevance. It also prepares trainees for successful careers in academic medicine and biomedical research.
Significance to patient care
Disorders of gut-brain interaction are common, chronic and costly. Changes in pressure-sensing ion channels and issues with how the gut senses and responds to physical forces are common in patients with these conditions. Diagnosis is often made only after other issues are ruled out first.
This process can be expensive and time-consuming, making it hard for both patients and medical teams. The goal of Dr. Beyder's academic career is to improve this approach.
Dr. Beyder feels fortunate to work at Mayo Clinic, where research on disorders of gut-brain interaction has a long history of excellence. Mayo is a global leader and collaborates with leading experts in the field. Together, they improve patients' lives by advancing understanding of these disorders and developing new tests and treatments.
Professional highlights
- Mayo Clinic:
- Research Career Impetus Award, 2026-2030.
- Fundamental Mechanisms of Aging Award, Robert and Arlene Kogod Center on Aging, 2023.
- New Investigator Award, Department of Medicine, 2019.
- Donald C. Balfour Award for Meritous Research, Mayo Clinic Alumni Association, 2014.
- J. Arnold Bargen Award for Gastroenterology Research, Mayo Clinic College of Medicine, 2014.
- American Gastroenterological Association:
- Young Investigator Award in basic and clinical science, 2021.
- Young Investigator Award in basic science, 2021.
- Research Scholar Award, 2015-2018.
- Director's New Innovator Award (DP2), National Institutes of Health, 2019.
- Research Career Enhancement Award, American Physiological Society, 2011.
- Young Investigator Award, American Neurogastroenterology and Motility Society, 2011.
- Clinician-investigator, General Mills Foundation, 2010.